Table 2 Clinical evaluation committee classification of causative microorganisms in community-acquired pneumonia patients
Tifacogin n = 251 | Placebo N = 245 | |||
|---|---|---|---|---|
Organism identified | Number (percentage) | Mortality, number (percentage) | Number (percentage) | Mortality, number (percentage) |
Streptococcus pneumoniae | 69 (27.5) | 14 (20.3) | 70 (28.6) | 19 (27.1) |
Staphylococcus aureus | 33 (13.1) | 14 (42.4) | 19 (7.8) | 12 (63.2) |
Haemophilus influenzae | 26 (10.4) | 5 (19.2) | 10 (4.1) | 5 (50) |
Other respiratory organisms | 24 (9.6) | 9 (37.5) | 23 (9.4) | 6 (26.1) |
Enteric Gram-negative | 20 (8.0) | 6 (30) | 16 (6.5) | 9 (56.3) |
Gram stain only | 9 (3.6) | 3 (33.3) | 9 (3.7) | 4 (44.4) |
Legionella species | 6 (2.4) | 1 (16.7) | 10 (4.1) | 2 (20) |
Pseudomonas aeruginosa | 6 (2.4) | 1 (16.7) | 12 (4.9) | 5 (41.7) |
Respiratory viruses | 2 (0.8) | 1 (50) | 0 | 0 |
Chlamydophila pneumoniae | 0 | 0 | 2 (0.8) | 0 |
No organism identified | 81 (32.3) | 91 (37.1) | ||